Total reported value
$55.3M
Reporting period: 2019-09-30 · Number of holdings: 55
Opus Point Partners Management, LLC disclosed 55 holdings in its latest 13F filing for the period ending 2019-09-30, with total reported value of $55.3M and a quarterly turnover rate of 27.3%.
Add IBB
0.0% -$2.0M
Trim LABUUSD
+1.4% -$1.9M
Add 34960Q109
+162.2% $514.0K
Add SGENEUR
+0.7% $300.0K
Add BMY
0.0% $176.0K
Trim QURE
0.0% -$551.0K
Showing top 54 holdings (of 55 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IBB | Ishares Biotechnology ETF | ETF-Tech | 37.76% | +3.86% | — | |
| 2 | LABUUSD | Drx Dly S&p Biotech Bull 3x | ETF-Tech | 5.58% | -1.73% | +1.45% | |
| 3 | MTD | Mettler-toledo International | Stock-Healthcare | 4.12% | +0.10% | — | |
| 4 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 3.02% | +0.81% | — | |
| 5 | SGENEUR | Seagen INC | Stock-Other | 2.78% | +0.95% | +0.66% | |
| 6 | ILMN | Illumina INC | Stock-Healthcare | 2.59% | +0.04% | +0.47% | |
| 7 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 2.54% | +0.32% | +1.05% | |
| 8 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 2.18% | +0.27% | — | |
| 9 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 1.99% | +0.56% | +2.49% | |
| 10 | ALXN | Alexion Pharmaceuticals INC | Stock-Other | 1.76% | -0.16% | +0.06% | |
| 11 | QGEN | Qiagen N.V. | Stock-Healthcare | 1.72% | -0.01% | — | |
| 12 | ONCEEUR | Spark Therapeutics INC | Stock-Other | 1.70% | +0.23% | — | |
| 13 | ✓ | Stock-Other | 1.56% | +1.04% | +162.17% | ||
| 14 | ✓ | Proqr Thrapeutics N V | Stock-Other | 1.44% | -0.42% | — | |
| 15 | INCY | Incyte CORP | Stock-Healthcare | 1.43% | +0.10% | +0.43% | |
| 16 | EXK | Exact Sciences CORP | Stock-Materials | 1.39% | -0.10% | — | |
| 17 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 1.22% | — | +9.82% | |
| 18 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 1.18% | -0.01% | +3.19% | |
| 19 | DCPHEUR | Deciphera Pharmaceuticals In | Stock-Other | 1.14% | +0.52% | — | |
| 20 | ASND | Ascendis Pharma A/S | Stock-Other | 1.08% | +0.03% | — | |
| 21 | QURE | uniQure N.V. | Stock-Other | 1.01% | -0.63% | — | |
| 22 | CELG | Celgene CORP | Stock-Other | 1.01% | +0.24% | — | |
| 23 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.98% | +0.06% | — | |
| 24 | EPZMEUR | Epizyme INC | Stock-Other | 0.94% | — | — | |
| 25 | ✓ | Amarin Corp PLC | Stock-Other | 0.92% | +0.44% | +102.16% | |
| 26 | 2655787D | Blueprint Medicines CORP | Stock-Other | 0.90% | -0.05% | — | |
| 27 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 0.88% | -0.09% | — | |
| 28 | GTHXEUR | G1 Therapeutics INC | Stock-Other | 0.86% | -0.09% | — | |
| 29 | GBTUSD | Global Blood Therapeutics In | Stock-Other | 0.83% | +0.09% | — | |
| 30 | BHVN | Biohaven Ltd. | Stock-Other | 0.82% | — | — | |
| 31 | ARNAEUR | Arena Pharmaceuticals INC | Stock-Other | 0.81% | -0.04% | — | |
| 32 | ACAD | Acadia Pharmaceuticals INC | Stock-Healthcare | 0.78% | +0.31% | +0.20% | |
| 33 | GWPH | Gw Pharmaceuticals LTD | Stock-Other | 0.76% | -0.18% | — | |
| 34 | ZGNXEUR | Zogenix INC | Stock-Other | 0.70% | +0.01% | — | |
| 35 | MGNX | Macrogenics INC | Stock-Other | 0.69% | -0.06% | — | |
| 36 | NTLA | Intellia Therapeutics INC | Stock-Other | 0.69% | — | — | |
| 37 | TECH | Bio-techne CORP | Stock-Healthcare | 0.55% | — | — | |
| 38 | IQV | Iqvia Holdings INC | Stock-Healthcare | 0.54% | — | — | |
| 39 | AMGN | Amgen INC | Stock-Healthcare | 0.53% | — | +8.66% | |
| 40 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 0.51% | — | +3.82% | |
| 41 | CKPTUSD | Checkpoint Therapeutics INC | Stock-Other | 0.51% | — | — | |
| 42 | CRL | Charles River Laboratories | Stock-Healthcare | 0.51% | — | — | |
| 43 | UTHR | United Therapeutics CORP | Stock-Healthcare | 0.50% | +0.50% | NEW | |
| 44 | GRFS | Grifols Sa-adr | Stock-Other | 0.48% | — | — | |
| 45 | BIIB | Biogen INC | Stock-Healthcare | 0.47% | — | — | |
| 46 | ICPTUSD | Intercept Pharmaceuticals In | Stock-Other | 0.47% | -0.22% | -33.14% | |
| 47 | GILD | Gilead Sciences INC | Stock-Healthcare | 0.47% | — | — | |
| 48 | LGND | Ligand Pharmaceuticals | Stock-Healthcare | 0.44% | — | +15.02% | |
| 49 | NKTREUR | Nektar Therapeutics | Stock-Other | 0.42% | -0.24% | +3.39% | |
| 50 | EXEL | Exelixis INC | Stock-Healthcare | 0.42% | — | +14.79% |
Not enough priced holdings yet to compute performance
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2019-09-30 | 55 | $55.3M | 27 | |
| 2019-06-30 | 63 | $67.6M | 18 | |
| 2019-03-31 | 75 | $73.8M | 55 | |
| 2018-12-31 | 40 | $45.4M | 96 | |
| 2018-09-30 | 47 | $41.9M | 62 | |
| 2018-06-30 | 50 | $46.1M | 45 | |
| 2018-03-31 | 51 | $51.0M | 98 | |
| 2017-12-31 | 65 | $115.6M | 31 | |
| 2017-09-30 | 63 | $111.5M | 100 | |
| 2017-06-30 | 66 | $108.6M | 0 | |
| 2017-03-31 | 67 | $134.7M | 39 | |
| 2016-12-31 | 57 | $125.5M | 49 | |
| 2016-09-30 | 50 | $178.3M | 61 | |
| 2016-06-30 | 43 | $103.5M | 48 | |
| 2016-03-31 | 52 | $129.4M | 65 | |
| 2015-12-31 | 57 | $151.4M | 83 | |
| 2015-09-30 | 56 | $181.1M | 70 | |
| 2015-06-30 | 57 | $126.3M | 36 | |
| 2015-03-31 | 65 | $119.3M | 44 | |
| 2014-12-31 | 60 | $101.1M | 0 |
Opus Point Partners Management, LLC's most significant position changes for 2019-09-30: Sold out: Immunomedics INC (IMMU); Sold out: Sarepta Therapeutics INC (SRPT); Sold out: ; Sold out: Insmed INC (INSM); Sold out: Pacira Biosciences INC (PCRX).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IBB | Ishares Biotechnology ETF | +3.9% | — | Unchanged |
| 2 | ✓ | +1% | +162.17% | Add | |
| 3 | SGENEUR | Seagen INC | +1% | +0.66% | Add |
| 4 | BMY | Bristol-myers Squibb Co | +0.8% | — | Unchanged |
| 5 | ALNY | Alnylam Pharmaceuticals INC | +0.6% | +2.49% | Add |
| 6 | DCPHEUR | Deciphera Pharmaceuticals In | +0.5% | — | Unchanged |
| 7 | ✓ | Amarin Corp PLC | +0.4% | +102.16% | Add |
| 8 | VRTX | Vertex Pharmaceuticals INC | +0.3% | +1.05% | Add |
| 9 | ACAD | Acadia Pharmaceuticals INC | +0.3% | +0.20% | Add |
| 10 | IONS | Ionis Pharmaceuticals INC | +0.3% | — | Unchanged |
| 11 | CELG | Celgene CORP | +0.2% | — | Unchanged |
| 12 | ONCEEUR | Spark Therapeutics INC | +0.2% | — | Unchanged |
| 13 | MTD | Mettler-toledo International | +0.1% | — | Unchanged |
| 14 | INCY | Incyte CORP | +0.1% | +0.43% | Add |
| 15 | GBTUSD | Global Blood Therapeutics In | +0.1% | — | Unchanged |
| 16 | CRSP | CRISPR Therapeutics AG | +0.1% | — | Unchanged |
| 17 | ILMN | Illumina INC | 0% | +0.47% | Add |
| 18 | ASND | Ascendis Pharma A/S | 0% | — | Unchanged |
| 19 | ZGNXEUR | Zogenix INC | 0% | — | Unchanged |
| 20 | EPZMEUR | Epizyme INC | — | — | Unchanged |
| 21 | NTLA | Intellia Therapeutics INC | — | — | Unchanged |
| 22 | CKPTUSD | Checkpoint Therapeutics INC | — | — | Unchanged |
| 23 | QGEN | Qiagen N.V. | 0% | — | Unchanged |
| 24 | BMRN | Biomarin Pharmaceutical INC | 0% | +3.19% | Add |
| 25 | ARNAEUR | Arena Pharmaceuticals INC | 0% | — | Unchanged |
| 26 | 2655787D | Blueprint Medicines CORP | -0.1% | — | Unchanged |
| 27 | MGNX | Macrogenics INC | -0.1% | — | Unchanged |
| 28 | BOLDEUR | Audentes Therapeutics INC | -0.1% | — | Unchanged |
| 29 | GTHXEUR | G1 Therapeutics INC | -0.1% | — | Unchanged |
| 30 | RARE | Ultragenyx Pharmaceutical In | -0.1% | — | Unchanged |
| 31 | EXK | Exact Sciences CORP | -0.1% | — | Unchanged |
| 32 | ALXN | Alexion Pharmaceuticals INC | -0.2% | +0.06% | Add |
| 33 | GWPH | Gw Pharmaceuticals LTD | -0.2% | — | Unchanged |
| 34 | ICPTUSD | Intercept Pharmaceuticals In | -0.2% | -33.14% | Trim |
| 35 | NKTREUR | Nektar Therapeutics | -0.2% | +3.39% | Add |
| 36 | ✓ | Proqr Thrapeutics N V | -0.4% | — | Unchanged |
| 37 | QURE | uniQure N.V. | -0.6% | — | Unchanged |
| 38 | LABUUSD | Drx Dly S&p Biotech Bull 3x | -1.7% | +1.45% | Add |
| 39 | IMMU | Immunomedics INC | — | EXIT | Sold out |
| 40 | SRPT | Sarepta Therapeutics INC | — | EXIT | Sold out |
| 41 | ✓ | — | EXIT | Sold out | |
| 42 | INSM | Insmed INC | — | EXIT | Sold out |
| 43 | PCRX | Pacira Biosciences INC | — | EXIT | Sold out |
| 44 | AM6 | Amicus Therapeutics INC | — | EXIT | Sold out |
| 45 | VKTX | Viking Therapeutics INC | — | EXIT | Sold out |
| 46 | MDGL | Madrigal Pharmaceuticals INC | — | EXIT | Sold out |
| 47 | ANAB | Anaptysbio INC | — | EXIT | Sold out |
| 48 | UTHR | United Therapeutics CORP | — | NEW | New buy |
| 49 | AGIO | Agios Pharmaceuticals INC | — | EXIT | Sold out |
| 50 | ALKS | Alkermes plc | — | NEW | New buy |